Retroperitoneal lymph node dissection after chemotherapy for germ cell tumours: Is a full bilateral template always necessary?

BJU International

Volumn 102, Issue 3, 2008, Pages 310-314

  Steiner, Hannes ^a   Peschel, Reinhard ^a   Bartsch, Georg ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Chemotherapy; RPLND; Testicular cancer

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE; IFOSFAMIDE;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EJACULATION; FIBROSIS; FOLLOW UP; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MESENTERIC ARTERY; METASTASIS; MULTIPLE CYCLE TREATMENT; NECROSIS; NON SEMINOMATOUS GERMINOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROPERITONEUM; SCHOOL CHILD; TERATOMA;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; COMBINED MODALITY THERAPY; EJACULATION; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, GERM CELL AND EMBRYONAL; PROGNOSIS; RETROPERITONEAL NEOPLASMS; TESTICULAR NEOPLASMS; TREATMENT OUTCOME;

EID: 47649129388     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.07579.x     Document Type: Article

References (26)

1. Sheinfeld JMJ, Bosl GJ. Surgery of testicular tumors. In Walsh PC, Vaughan ED, Wein AJ, Campell's Urology, 8th edn. Philadelphia : WB Saunders, 2002 : 2920 44
2. Beck SFR, Bihrle R, Donohue J. Is full bilateral retroperitoneal lymph node dissection always necessary for post chemotherapy residual tumor? J Urol 2005 173 (Suppl. 117
3. Wood DP Jr, Herr HW, Heller G et al. Distribution of retroperitoneal metastases after chemotherapy in patients with nonseminomatous germ cell tumors. J Urol 1992 148 : 1812 5
4. Herr HW. Does necrosis on frozen-section analysis of a mass after chemotherapy justify a limited retroperitoneal resection in patients with advanced testis cancer? Br J Urol 1997 80 : 653 7
5. Oldenburg J, Alfsen GC, Lien HH, Aass N, Waehre H, Fossa SD. Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses. J Clin Oncol 2003 21 : 3310 7
6. Weissbach L, Boedefeld EA. Localization of solitary and multiple metastases in stage II nonseminomatous testis tumor as basis for a modified staging lymph node dissection in stage I. J Urol 1987 138 : 77 82
7. Ehrlich Y, Yossepowitch O, Kedar D, Baniel J. Distribution of nodal metastases after chemotherapy in nonseminomatous testis cancer: a possible indication for limited dissection. BJU Int 2006 97 : 1221 4
8. Janetschek G, Hobisch A, Hittmair A, Holtl L, Peschel R, Bartsch G. Laparoscopic retroperitoneal lymphadenectomy after chemotherapy for stage IIB nonseminomatous testicular carcinoma. J Urol 1999 161 : 477 81
9. Hobisch A, Colleselli K, Ennemoser O et al. Modified retroperitoneal lymphadenectomy for testicular tumor: anatomical approach, operative technique and results. Eur Urol 1993 23 (Suppl. 2 39 43
10. Colleselli K, Poisel S, Schachtner W, Bartsch G. Nerve-preserving bilateral retroperitoneal lymphadenectomy: anatomical study and operative approach. J Urol 1990 144 : 293 7
11. Albers P, Perabo FG, Melchior D, Siener R. Adjuvant chemotherapy in stage I and stage II testicular cancer. World J Urol 2001 19 : 76 81
12. Sternberg CN. Role of primary chemotherapy in stage I and low-volume stage II nonseminomatous germ-cell testis tumors. Urol Clin North Am 1993 20 : 93 109
13. Debono DJ, Heilman DK, Einhorn LH, Donohue JP. Decision analysis for avoiding postchemotherapy surgery in patients with disseminated nonseminomatous germ cell tumors. J Clin Oncol 1997 15 : 1455 64
14. Donohue JP, Foster RS, Rowland RG, Bihrle R, Jones J, Geier G. Nerve-sparing retroperitoneal lymphadenectomy with preservation of ejaculation. J Urol 1990 144 : 287 91
15. Donohue JP, Thornhill JA, Foster RS, Rowland RG, Bihrle R. Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965-89). modifications of technique and impact on ejaculation. J Urol 1993 149 : 237 43
16. Carver BS, Shayegan B, Eggener S et al. Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection. J Clin Oncol 2007 25 : 4365 9
17. Donohue JP, Zachary JM, Maynard BR. Distribution of nodal metastases in nonseminomatous testis cancer. J Urol 1982 128 : 315 20
18. Gelderman WA, Koops HS, Sleijfer DT, Oosterhuis JW, Oldhoff J. Treatment of retroperitoneal residual tumor after PVB chemotherapy of nonseminomatous testicular tumors. Cancer 1986 58 : 1418 21
19. Hollins GW, Thomas S, Lanigan DJ et al. Retroperitoneal surgery: its wider role in the management of malignant teratoma. Br J Urol 1996 77 : 571 6
20. Horwich A, Norman A, Fisher C, Hendry WF, Nicholls J, Dearnaley DP. Primary chemotherapy for stage II nonseminomatous germ cell tumors of the testis. J Urol 1994 151 : 72 7
21. Hendry WF, A'Hern RP, Hetherington JW, Peckham MJ, Dearnaley DP, Horwich A. Para-aortic lymphadenectomy after chemotherapy for metastatic non-seminomatous germ cell tumours: prognostic value and therapeutic benefit. Br J Urol 1993 71 : 208 13
22. Rabbani F, Goldenberg SL, Gleave ME, Paterson RF, Murray N, Sullivan LD. Retroperitoneal lymphadenectomy for post-chemotherapy residual masses: is a modified dissection and resection of residual masses sufficient? Br J Urol 1998 81 : 295 300
23. Suzuki K, Orikasa S, Hoshi S et al. The significance of resections for residual masses after chemotherapy in metastatic testicular tumors. Int J Urol 1999 6 : 305 13
24. Foster RS, Beck S, Bihrle R. Secondary surgery in germ cell tumors - when and how extensively should it be performed? World J Urol 2004 22 : 37 40
25. Horwich A, Cullen MH, Stenning SP. Primary chemotherapy after orchidectomy for stage I and II nonseminoma. Semin Oncol 1998 25 : 154 9
26. Weissbach L, Bussar-Maatz R, Flechtner H, Pichlmeier U, Hartmann M, Keller L. RPLND or primary chemotherapy in clinical stage IIA/B nonseminomatous germ cell tumors? Results of a prospective multicenter trial including quality of life assessment. Eur Urol 2000 37 : 582 94